Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
SRP-3D by South Rampart Pharma for Neuropathic Pain (Neuralgia): Likelihood of Approval
SRP-3D is under clinical development by South Rampart Pharma and currently in Phase I for Neuropathic Pain (Neuralgia). According to...
Data Insights
SRP-3D by South Rampart Pharma for Pain: Likelihood of Approval
SRP-3D is under clinical development by South Rampart Pharma and currently in Phase I for Pain. According to GlobalData, Phase...